Free Trial

RLI (NYSE:RLI) Price Target Raised to $185.00

RLI logo with Finance background

RLI (NYSE:RLI - Get Free Report) had its target price boosted by equities researchers at Compass Point from $170.00 to $185.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has a "buy" rating on the insurance provider's stock. Compass Point's target price points to a potential upside of 19.12% from the company's previous close.

Several other research firms have also commented on RLI. Jefferies Financial Group upped their price objective on RLI from $165.00 to $180.00 and gave the stock a "buy" rating in a research note on Wednesday, October 9th. JMP Securities restated a "market perform" rating on shares of RLI in a research report on Tuesday, July 23rd. Wolfe Research began coverage on RLI in a research report on Wednesday, October 9th. They set an "outperform" rating and a $182.00 price objective on the stock. Oppenheimer assumed coverage on shares of RLI in a report on Wednesday, October 16th. They issued a "market perform" rating for the company. Finally, Keefe, Bruyette & Woods lifted their price target on shares of RLI from $169.00 to $175.00 and gave the company an "outperform" rating in a report on Monday, July 29th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $177.40.

Get Our Latest Analysis on RLI

RLI Stock Performance

NYSE:RLI traded down $3.92 on Friday, hitting $155.30. The stock had a trading volume of 113,859 shares, compared to its average volume of 154,336. The business's 50-day simple moving average is $154.75 and its two-hundred day simple moving average is $147.21. The stock has a market cap of $7.10 billion, a price-to-earnings ratio of 17.07 and a beta of 0.41. RLI has a 52-week low of $125.77 and a 52-week high of $164.25. The company has a quick ratio of 0.39, a current ratio of 0.39 and a debt-to-equity ratio of 0.06.

RLI (NYSE:RLI - Get Free Report) last posted its quarterly earnings data on Monday, October 21st. The insurance provider reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.98 by $0.33. RLI had a net margin of 23.77% and a return on equity of 19.03%. The company had revenue of $470.00 million for the quarter, compared to the consensus estimate of $491.54 million. During the same quarter last year, the firm posted $0.61 earnings per share. The firm's revenue was up 41.7% compared to the same quarter last year. As a group, research analysts predict that RLI will post 6.07 earnings per share for the current year.

Institutional Trading of RLI

A number of institutional investors and hedge funds have recently bought and sold shares of RLI. Dimensional Fund Advisors LP grew its position in shares of RLI by 2.7% during the second quarter. Dimensional Fund Advisors LP now owns 931,454 shares of the insurance provider's stock valued at $131,045,000 after purchasing an additional 24,125 shares in the last quarter. Maren Capital LLC increased its stake in RLI by 21.3% in the 1st quarter. Maren Capital LLC now owns 612,081 shares of the insurance provider's stock worth $90,876,000 after acquiring an additional 107,655 shares during the last quarter. Van Berkom & Associates Inc. raised its holdings in shares of RLI by 1.5% during the 2nd quarter. Van Berkom & Associates Inc. now owns 556,764 shares of the insurance provider's stock worth $78,331,000 after acquiring an additional 8,454 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of RLI by 0.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 428,331 shares of the insurance provider's stock valued at $60,262,000 after acquiring an additional 1,979 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its holdings in shares of RLI by 14.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 265,365 shares of the insurance provider's stock valued at $39,400,000 after purchasing an additional 33,435 shares in the last quarter. 77.89% of the stock is currently owned by institutional investors.

About RLI

(Get Free Report)

RLI Corp., an insurance holding company, underwrites property and casualty insurance. Its Casualty segment provides commercial and personal coverage products; and general liability products, such as coverage for third-party liability of commercial insureds, including manufacturers, contractors, apartments, and mercantile.

Featured Stories

Analyst Recommendations for RLI (NYSE:RLI)

Should you invest $1,000 in RLI right now?

Before you consider RLI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RLI wasn't on the list.

While RLI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines